Works matching IS 23744677 AND DT 2022 AND VI 8 AND IP 1

Results: 133
    1
    2
    3

    A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00500-3
    By:
    • Ademuyiwa, Foluso O.;
    • Gao, Feng;
    • Street, Cherease R.;
    • Chen, Ina;
    • Northfelt, Donald W.;
    • Wesolowski, Robert;
    • Arora, Mili;
    • Brufsky, Adam;
    • Dees, E. Claire;
    • Santa-Maria, Cesar A.;
    • Connolly, Roisin M.;
    • Force, Jeremy;
    • Moreno-Aspitia, Alvaro;
    • Herndon, John M.;
    • Carmody, Madelyn;
    • Davies, Sherri R.;
    • Larson, Sarah;
    • Pfaff, Kathleen L.;
    • Jones, Stephanie M.;
    • Weirather, Jason L.
    Publication type:
    Article
    4
    5

    Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy.

    Published in:
    2022
    By:
    • Gharbi, Severine Isabelle;
    • Pelletier, Laura A.;
    • Espada, Alfonso;
    • Gutiérrez, Jesus;
    • Sanfeliciano, Sonia Maria Gutiérrez;
    • Rauch, Charles T.;
    • Ganado, Maria Patricia;
    • Baquero, Carmen;
    • Zapatero, Elisabet;
    • Zhang, Aiping;
    • Benach, Jordi;
    • Russell, Anna-Maria;
    • Cano, Leticia;
    • Gomez, Sandra;
    • Broughton, Howard;
    • Pulliam, Nicholas;
    • Perez, Carmen Maria;
    • Torres, Raquel;
    • Debets, Marjoke F.;
    • de Dios, Alfonso
    Publication type:
    Correction Notice
    6
    7

    Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00496-w
    By:
    • Sandbank, Judith;
    • Bataillon, Guillaume;
    • Nudelman, Alona;
    • Krasnitsky, Ira;
    • Mikulinsky, Rachel;
    • Bien, Lilach;
    • Thibault, Lucie;
    • Albrecht Shach, Anat;
    • Sebag, Geraldine;
    • Clark, Douglas P.;
    • Laifenfeld, Daphna;
    • Schnitt, Stuart J.;
    • Linhart, Chaim;
    • Vecsler, Manuela;
    • Vincent-Salomon, Anne
    Publication type:
    Article
    8

    Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00493-z
    By:
    • Lang, Julie E.;
    • Forero-Torres, Andres;
    • Yee, Douglas;
    • Yau, Christina;
    • Wolf, Denise;
    • Park, John;
    • Parker, Barbara A.;
    • Chien, A. Jo;
    • Wallace, Anne M.;
    • Murthy, Rashmi;
    • Albain, Kathy S.;
    • Ellis, Erin D.;
    • Beckwith, Heather;
    • Haley, Barbara B.;
    • Elias, Anthony D.;
    • Boughey, Judy C.;
    • Yung, Rachel L.;
    • Isaacs, Claudine;
    • Clark, Amy S.;
    • Han, Hyo S.
    Publication type:
    Article
    9

    Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00487-x
    By:
    • Makhlin, Igor;
    • McAndrew, Nicholas P.;
    • Wileyto, E. Paul;
    • Clark, Amy S.;
    • Holmes, Robin;
    • Bottalico, Lisa N.;
    • Mesaros, Clementina;
    • Blair, Ian A.;
    • Jeschke, Grace R.;
    • Fox, Kevin R.;
    • Domchek, Susan M.;
    • Matro, Jennifer M.;
    • Bradbury, Angela R.;
    • Feldman, Michael D.;
    • Hexner, Elizabeth O.;
    • Bromberg, Jacqueline F.;
    • DeMichele, Angela
    Publication type:
    Article
    10
    11
    12
    13
    14

    Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT).

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00495-x
    By:
    • Sella, Tal;
    • Zheng, Yue;
    • Tayob, Nabihah;
    • Ruddy, Kathryn J.;
    • Freedman, Rachel A.;
    • Dang, Chau;
    • Yardley, Denise;
    • Isakoff, Steven J.;
    • Valero, Vicente;
    • DeMeo, Michelle;
    • Burstein, Harold J.;
    • Winer, Eric P.;
    • Wolff, Antonio C.;
    • Krop, Ian;
    • Partridge, Ann H.;
    • Tolaney, Sara M.
    Publication type:
    Article
    15

    Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00494-y
    By:
    • Gharbi, Severine Isabelle;
    • Pelletier, Laura A.;
    • Espada, Alfonso;
    • Gutiérrez, Jesus;
    • Sanfeliciano, Sonia Maria Gutiérrez;
    • Rauch, Charles T.;
    • Ganado, Maria Patricia;
    • Baquero, Carmen;
    • Zapatero, Elisabet;
    • Zhang, Aiping;
    • Benach, Jordi;
    • Russell, Anna-Maria;
    • Cano, Leticia;
    • Gomez, Sandra;
    • Broughton, Howard;
    • Pulliam, Nicholas;
    • Perez, Carmen Maria;
    • Torres, Raquel;
    • Debets, Marjoke F.;
    • de Dios, Alfonso
    Publication type:
    Article
    16

    Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00488-w
    By:
    • Mercan, Caner;
    • Balkenhol, Maschenka;
    • Salgado, Roberto;
    • Sherman, Mark;
    • Vielh, Philippe;
    • Vreuls, Willem;
    • Polónia, António;
    • Horlings, Hugo M.;
    • Weichert, Wilko;
    • Carter, Jodi M.;
    • Bult, Peter;
    • Christgen, Matthias;
    • Denkert, Carsten;
    • van de Vijver, Koen;
    • Bokhorst, John-Melle;
    • van der Laak, Jeroen;
    • Ciompi, Francesco
    Publication type:
    Article
    17

    Deep learning models for histologic grading of breast cancer and association with disease prognosis.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00478-y
    By:
    • Jaroensri, Ronnachai;
    • Wulczyn, Ellery;
    • Hegde, Narayan;
    • Brown, Trissia;
    • Flament-Auvigne, Isabelle;
    • Tan, Fraser;
    • Cai, Yuannan;
    • Nagpal, Kunal;
    • Rakha, Emad A.;
    • Dabbs, David J.;
    • Olson, Niels;
    • Wren, James H.;
    • Thompson, Elaine E.;
    • Seetao, Erik;
    • Robinson, Carrie;
    • Miao, Melissa;
    • Beckers, Fabien;
    • Corrado, Greg S.;
    • Peng, Lily H.;
    • Mermel, Craig H.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00480-4
    By:
    • Setayesh, Sonia Maryam;
    • Hart, Olivia;
    • Naghdloo, Amin;
    • Higa, Nikki;
    • Nieva, Jorge;
    • Lu, Janice;
    • Hwang, Shelley;
    • Wilkinson, Kathy;
    • Kidd, Michael;
    • Anderson, Amanda;
    • Velasco, Carmen Ruiz;
    • Kolatkar, Anand;
    • Matsumoto, Nicholas;
    • Nevarez, Rafael;
    • Hicks, James B.;
    • Mason, Jeremy;
    • Shishido, Stephanie N.;
    • Kuhn, Peter
    Publication type:
    Article
    25
    26
    27
    28

    Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00477-z
    By:
    • Loibl, Sibylle;
    • Huang, Chiun-Sheng;
    • Mano, Max S.;
    • Mamounas, Eleftherios P.;
    • Geyer Jr, Charles E.;
    • Untch, Michael;
    • Thery, Jean-Christophe;
    • Schwaner, Ingo;
    • Limentani, Steven;
    • Loman, Niklas;
    • Lübbe, Kristina;
    • Chang, Jenny C.;
    • Hatschek, Thomas;
    • Tesarowski, David;
    • Song, Chunyan;
    • Lysbet de Haas, Sanne;
    • Boulet, Thomas;
    • Lambertini, Chiara;
    • Wolmark, Norman
    Publication type:
    Article
    29
    30
    31
    32
    33

    Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00463-5
    By:
    • Karagiannis, George S.;
    • Bianchi, Anthony;
    • Sanchez, Luis Rivera;
    • Ambadipudi, Kamal;
    • Cui, Min-Hui;
    • Anampa, Jesus M.;
    • Asiry, Saeed;
    • Wang, Yarong;
    • Harney, Allison S.;
    • Pastoriza, Jessica M.;
    • Lin, Yu;
    • Chen, Xiaoming;
    • Jones, Joan G.;
    • Entenberg, David;
    • Haddad, Dana;
    • Hodges, Laura J.;
    • Duong, Timothy Q.;
    • Sparano, Joseph A.;
    • Oktay, Maja H.;
    • Branch, Craig A.
    Publication type:
    Article
    34
    35
    36
    37
    38

    ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00470-6
    By:
    • Strillacci, Antonio;
    • Sansone, Pasquale;
    • Rajasekhar, Vinagolu K.;
    • Turkekul, Mesruh;
    • Boyko, Vitaly;
    • Meng, Fanli;
    • Houck-Loomis, Brian;
    • Brown, David;
    • Berger, Michael F.;
    • Hendrickson, Ronald C.;
    • Chang, Qing;
    • de Stanchina, Elisa;
    • Pareja, Fresia;
    • Reis-Filho, Jorge S.;
    • Rajappachetty, Ramya Segu;
    • Del Priore, Isabella;
    • Liu, Bo;
    • Cai, Yanyan;
    • Penson, Alex;
    • Mastroleo, Chiara
    Publication type:
    Article
    39
    40

    RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00465-3
    By:
    • Staaf, Johan;
    • Häkkinen, Jari;
    • Hegardt, Cecilia;
    • Saal, Lao H.;
    • Kimbung, Siker;
    • Hedenfalk, Ingrid;
    • Lien, Tonje;
    • Sørlie, Therese;
    • Naume, Bjørn;
    • Russnes, Hege;
    • Marcone, Rachel;
    • Ayyanan, Ayyakkannu;
    • Brisken, Cathrin;
    • Malterling, Rebecka R.;
    • Asking, Bengt;
    • Olofsson, Helena;
    • Lindman, Henrik;
    • Bendahl, Pär-Ola;
    • Ehinger, Anna;
    • Larsson, Christer
    Publication type:
    Article
    41

    Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00467-1
    By:
    • Rugo, Hope S.;
    • Tolaney, Sara M.;
    • Loirat, Delphine;
    • Punie, Kevin;
    • Bardia, Aditya;
    • Hurvitz, Sara A.;
    • O'Shaughnessy, Joyce;
    • Cortés, Javier;
    • Diéras, Véronique;
    • Carey, Lisa A.;
    • Gianni, Luca;
    • Piccart, Martine J.;
    • Loibl, Sibylle;
    • Goldenberg, David M.;
    • Hong, Quan;
    • Olivo, Martin;
    • Itri, Loretta M.;
    • Kalinsky, Kevin
    Publication type:
    Article
    42
    43
    44

    The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00453-7
    By:
    • Isnaldi, Edoardo;
    • Richard, François;
    • De Schepper, Maxim;
    • Leduc, Sophia;
    • Maetens, Marion;
    • Geukens, Tatjana;
    • Van Baelen, Karen;
    • Nguyen, Ha-Linh;
    • Rouas, Ghizlane;
    • Zoppoli, Gabriele;
    • Cardoso, Fatima;
    • Sotiriou, Christos;
    • Larsimont, Denis;
    • Floris, Giuseppe;
    • Biganzoli, Elia;
    • Desmedt, Christine
    Publication type:
    Article
    45

    Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00455-5
    By:
    • Aarnoutse, Romy;
    • Ziemons, Janine;
    • Hillege, Lars E.;
    • de Vos-Geelen, Judith;
    • de Boer, Maaike;
    • Bisschop, Saskia M. P.;
    • Vriens, Birgit E. P. J.;
    • Vincent, Jeroen;
    • van de Wouw, Agnes J.;
    • Le, Giang N.;
    • Venema, Koen;
    • Rensen, Sander S.;
    • Penders, John;
    • Smidt, Marjolein L.
    Publication type:
    Article
    46
    47

    PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00452-8
    By:
    • Agostinetto, Elisa;
    • Ameye, Lieveke;
    • Martel, Samuel;
    • Aftimos, Philippe;
    • Pondé, Noam;
    • Maurer, Christian;
    • El-Abed, Sarra;
    • Wang, Yingbo;
    • Vicente, Malou;
    • Chumsri, Saranya;
    • Bliss, Judith;
    • Kroep, Judith;
    • Colleoni, Marco;
    • Petrelli, Fausto;
    • Del Mastro, Lucia;
    • Moreno-Aspitia, Alvaro;
    • Piccart, Martine;
    • Paesmans, Marianne;
    • de Azambuja, Evandro;
    • Lambertini, Matteo
    Publication type:
    Article
    48
    49
    50

    TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00446-6
    By:
    • Agyemang, Kojo;
    • Johansen, Allan M.;
    • Barker, Grayson W.;
    • Pennison, Michael J.;
    • Sheffield, Kimberly;
    • Jimenez, Hugo;
    • Blackman, Carl;
    • Sharma, Sambad;
    • Fordjour, Patrick A.;
    • Singh, Ravi;
    • Cook, Katherine L.;
    • Lin, Hui-Kuan;
    • Zhang, Wei;
    • Lo, Hui-Wen;
    • Watabe, Kounosuke;
    • Sun, Peiqing;
    • Langefeld, Carl D.;
    • Pasche, Boris
    Publication type:
    Article